A personalized treatment paradigm based on hypoxia imaging is promising and may yield a successful, personalized de-escalation strategy for patients with HPV-associated oropharynx cancer.
Kaveh Zakeri, MD, MAS
Advertisement
Articles by Kaveh Zakeri, MD, MAS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Epcoritamab Plus Lenalidomide and Rituximab Shows Consistent Efficacy Across R/R Follicular Lymphoma Subgroups
2
In Vivo CAR T-Cell Therapy Drives Responses and MRD Negativity in R/R Myeloma
3
Azacitidine/Ivosidenib/Venetoclax Generates High ORRs in IDH1-Mutant Newly Diagnosed AML
4
FDA Approves Adjuvant Belzutifan Plus Pembrolizumab in ccRCC
5